Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

4.68USD
1:15pm EST
Change (% chg)

$-0.37 (-7.33%)
Prev Close
$5.05
Open
$5.07
Day's High
$5.07
Day's Low
$4.57
Volume
51,195
Avg. Vol
45,149
52-wk High
$10.86
52-wk Low
$2.93

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 5.11 -0.284
Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
FY 2016 Dec '16 6.22 -0.602
Sep '16 5.92 -0.766
Jun '16 6.66 -0.914
Mar '16 6.35 -0.900
FY 2015 Dec '15 6.84 -0.823
Sep '15 4.69 -0.814
Jun '15 4.69 -0.720
Mar '15 9.69 -0.486
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 4.63 6.30 0.00 22.54
Quarter Ending Mar-18 3 5.40 6.20 5.00 --
Year Ending Dec-17 7 21.71 26.40 12.41 98.14
Year Ending Dec-18 7 27.36 48.20 18.00 59.46
Earnings (per share)
Quarter Ending Dec-17 7 -0.35 -0.27 -0.52 -0.45
Quarter Ending Mar-18 3 -0.32 -0.27 -0.41 --
Year Ending Dec-17 7 -1.61 -1.53 -1.70 -1.44
Year Ending Dec-18 7 -1.35 -1.10 -1.69 -2.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. -- 274.30 45.27
P/E Low - Last 5 Yrs. -- 92.17 24.24
Beta 2.78 0.83 0.91
Price to Sales (TTM) 8.06 113.99 5.83
Price to Book (MRQ) -- 21.50 5.68
Price to Tangible Book (MRQ) -- 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions 73.08 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -13.74 -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago -7.92 30.21 5.65
Sales - 5 Yr. Growth Rate -4.35 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 62.95 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago 42.05 -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate -12.42 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 3.39 5.75 3.56
LT Debt to Equity (MRQ) -- 14.45 13.23
Total Debt to Equity (MRQ) -- 16.90 19.24
Interest Coverage (TTM) -- -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.05 54.80
Gross Margin - 5 Yr. Avg. -- 55.37 52.40
EBITD Margin (TTM) -283.90 -- --
EBITD - 5 Yr. Avg -181.75 -219.17 15.52
Operating Margin (TTM) -301.74 -631.99 6.76
Operating Margin - 5 Yr. Avg. -186.73 -236.03 11.03
Pre-Tax Margin (TTM) -298.55 -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. -186.42 -236.35 11.44
Net Profit Margin (TTM) -298.60 -600.25 3.81
Net Profit Margin - 5 Yr. Avg. -187.38 -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,525 21,633,432 858,823,705
Net Income/Employee (TTM) -580,844 -1,703,997 100,224,560
Receivable Turnover (TTM) 18.28 25.40 6.12
Inventory Turnover (TTM) -- 2.62 3.55
Asset Turnover (TTM) 0.14 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.85 -9.13 11.35
Return on Assets - 5 Yr. Avg. -27.30 0.30 12.32
Return on Investment (TTM) -56.95 -11.32 14.47
Return on Investment - 5 Yr. Avg. -34.15 3.50 16.13
Return on Equity (TTM) -- -35.69 16.06
Return on Equity - 5 Yr. Avg. -- 5.92 17.32
  1 Year 3 Year 5 Year
Sales % -2.88 -12.68 -4.35
EPS (TTM) % -10.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.70 0.99 68 96
13 Week 12.22 4.18 71 71
26 Week 39.50 27.94 82 64
52 Week -33.90 -44.00 24 62
YTD -34.50 -44.69 23 49
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.86%
# of Holders: 81
Total Shares Held: 29,098,106
3 Mo. Net Change: 207,000
# New Positions: 5
# Closed Positions: 23
# Increased Positions: 27
# Reduced Positions: 45
# Net Buyers: -18
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.